An observational study in Acne, Atopic Dermatitis and Chronic Hand Eczema, sponsored by Innovaderm Research Inc.. Recruiting at 1 site in Canada. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-28.
Sponsored by Innovaderm Research Inc. · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 59 studies in Acne Vulgaris with a site in Canada — 4 open to participants now, 5 under way, none of them phase 3. Acne Vulgaris · Canada.
Among the 59 studies in Acne Vulgaris with a site in Canada, this one is the only one that started in 2023, is one of 3 observational ones, and was the 53rd registered.
795 studies on the registry are indexed under Acne Vulgaris; 96 are open to participants now.
Browse Acne Vulgaris studies →4 of the 59 studies in Acne Vulgaris with a site in Canada are open now. Recruiting first, the newest first:
Sanofi · Sites in Canada
Ages 12–17
Sanofi Pasteur, a Sanofi Company · Sites in Canada, United States, Australia and 1 more country
Ages 18–45
GenCanna Acquisition Corp · Sites in Canada
Ages 18–65
A study can be open while its sites in Canada have not opened yet or have stopped. Only those recruiting at a site in Canada →
Of the 48 Acne Vulgaris studies recruiting now, 17 (35%) set no upper age limit and 30 (63%) stop at 75 or younger; 21 take children under 18; 17 take healthy volunteers.
This study: 18 Years and older · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
59 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 9 · Phase 2 15 · Phase 3 25 · Phase 4 6
First in 2004; this study’s year is marked. 1 started in 2023.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 500 is above the median of 89 across 96 observational studies indexed under Acne Vulgaris.
Median enrollment 257 across the 56 interventional studies, 200 across the 3 observational. Of the 51 that completed or were terminated, 34 (67%) have results posted.
This tab as a report to print or save as PDF → With an account.
53 of 59 have an industry lead sponsor. The 10 most frequent:
Innovaderm Research Inc. is the lead sponsor of 34 studies on the registry; 2 are open to participants now.
Innovaderm Research Inc. has 2 studies filed under Acne Vulgaris — fewer than ten, so there is no comparison to draw.
None of the studies under way reaches primary completion within a year.
Among the 59 studies in Acne Vulgaris with a site in Canada, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The purpose of the study is to collect different samples for molecular characterization of inflammatory skin diseases.
This study is being conducted to collect samples from subjects with various skin conditions as well as healthy volunteers. Collected samples may be used for different analyses including, but not limited to, biomarker and gene expression analyses.
Approximately 200 healthy volunteers and approximately 300 subjects with acne, atopic dermatitis (AD), chronic hand eczema (CHE), hidradenitis suppurativa (HS), palmoplantar pustulosis (PPP), and/or psoriasis will be included in this study.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
All subjects:
Subject must be willing to comply with all study procedures and must be available for the duration of the study.
Healthy volunteers:
Subject is in good general health, according to the investigator's judgment.
Subjects with Acne:
Male or female subject aged 18 to 45 years old, inclusive, at the time of consent.
Subjects with AD:
Subject has clinically confirmed diagnosis of active AD, according to Hanifin and Rajka criteria.
Subjects with CHE:
Subject has at least a 6-month history of CHE before Screening (information obtained from medical chart or subject's physician, or directly from the subject).
Subjects with HS:
Subject has a clinically confirmed diagnosis of active HS with a disease duration of ≥ 6 months before screening as determined by the investigator through subject interview and/or review of the medical history.
Subjects with PPP:
Subject has at least a 6-month history of PPP as defined by the presence of pustules on palms and/or soles, but without evidence of infection on palms and soles (information obtained from medical chart or subject's physician, or directly from the subject).
Subjects with psoriasis:
Exclusion Criteria:
All subjects:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Informed consent
Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorized to decide for you.
You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Healthy adults
Procedure: Blood samples collection · Procedure: Oral samples collection · Procedure: Hair samples collection · Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping) · Procedure: Skin surface material samples · Procedure: Drainage fluid samples collection · Procedure: Stool samples collection
Adult subjects aged 18 to 45 years old with acne
Procedure: Blood samples collection · Procedure: Oral samples collection · Procedure: Hair samples collection · Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping) · Procedure: Skin surface material samples · Procedure: Drainage fluid samples collection · Procedure: Stool samples collection
Adult subjects with Atopic Dermatitis (AD)
Procedure: Blood samples collection · Procedure: Oral samples collection · Procedure: Hair samples collection · Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping) · Procedure: Skin surface material samples · Procedure: Drainage fluid samples collection · Procedure: Stool samples collection
Adult subjects with Chronic Hand Eczema (CHE)
Procedure: Blood samples collection · Procedure: Oral samples collection · Procedure: Hair samples collection · Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping) · Procedure: Skin surface material samples · Procedure: Drainage fluid samples collection · Procedure: Stool samples collection
Adult subjects with Hidradenitis suppurativa (HS)
Procedure: Blood samples collection · Procedure: Oral samples collection · Procedure: Hair samples collection · Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping) · Procedure: Skin surface material samples · Procedure: Drainage fluid samples collection · Procedure: Stool samples collection
Adult subjects with Palmoplantar pustulosis (PPP)
Procedure: Blood samples collection · Procedure: Oral samples collection · Procedure: Hair samples collection · Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping) · Procedure: Skin surface material samples · Procedure: Drainage fluid samples collection · Procedure: Stool samples collection
Adult subjects with Psoriasis
Procedure: Blood samples collection · Procedure: Oral samples collection · Procedure: Hair samples collection · Procedure: Skin samples collection (skin tape strip and/or skin biopsy, and/or skin scraping) · Procedure: Skin surface material samples · Procedure: Drainage fluid samples collection · Procedure: Stool samples collection
biomarkers and optional genetic analysis
biomarkers analysis
biomarkers analysis
biomarkers analysis
biomarkers analysis
biomarkers analysis
biomarkers analysis
Untargeted biomarker approach with gene expression profile of skin samples
Time frame: Day 1
Exploratory biomarker and gene expression analyses.
Time frame: Day 1
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2023 (actual). Primary completion is estimated for Aug 2028, 58 months after the start.
How these figures are worked out, and which studies are left out of them.
From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Innovaderm Research Inc.